NCT03240965 Changes in Sensitivity, Taste and Smell in Stroke Patients
| NCT ID | NCT03240965 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Giessen |
| Condition | Dysphagia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2017-10-01 |
| Primary Completion | 2025-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2017-10-01 with a primary completion date of 2025-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates changes in swallowing using endoscopic swallowing studies and measuring of pharyngeal sensitivity, taste and smell in stroke patients. Younger (\<60 years) and older (\>60 years) volunteers will serve as control.
Eligibility Criteria
Inclusion Criteria: Volunteers: * informed consent Stroke patients: * informed consent * new supratentorial stroke (\<72 hours old) confirmed by CT (computed tomography) or MRI (magnetic resonance imaging) Exclusion Criteria: * pre-existing stroke oder dysphagia * extensive white matter lesions in CT- or MRI-scan * allergies to odorous substances or flavoring * contraindications for FEES (flexible endoscopic evaluation of swallowing), CT or MRI (stroke patients only)
Contact & Investigator
Tobias Braun, M.D.
PRINCIPAL INVESTIGATOR
University Giessen
Frequently Asked Questions
Who can join the NCT03240965 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dysphagia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03240965 currently recruiting?
Yes, NCT03240965 is actively recruiting participants. Contact the research team at tobias.braun@neuro.med.uni-giessen.de for enrollment information.
Where is the NCT03240965 trial being conducted?
This trial is being conducted at Giessen, Germany.
Who is sponsoring the NCT03240965 clinical trial?
NCT03240965 is sponsored by University of Giessen. The principal investigator is Tobias Braun, M.D. at University Giessen. The trial plans to enroll 200 participants.